Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.833 6 days ( 0.82 % )
Last Price $3.65 0 %
High/ Low $3.65 - $3.65 -0.82%
Chg 7 Days -0.82 % $3.68 $3.65
Chg 30 Days -8.75 % $4.00 $3.65
Chg 12 mos -52.35 % $7.66 $3.65
Trend - 3 mos -10.90 % Width: 24.11 %
Trend - 12 mos -44.36 % Width: 206.11 %
Pred. range - 3 mos $2.91 - $3.61 -20.21 % - -0.97 %
Pred. range - 12 mos $1.06 - $3.25 -70.90 % - -10.92 %
Short MA avg 3 mos Sell Jun 12, 2024 - 4 days
Long MA avg 3 mos Sell May 22, 2024 - 19 days
Short/Long MA avg 3 mos Sell May 30, 2024 - 13 days
Short MA avg 12 mos Sell May 22, 2024 - 19 days
Long MA avg 12 mos Sell Mar 04, 2024 - 74 days
Short/Long MA avg 12 mos Sell Mar 18, 2024 - 64 days
Pivot Short Buy Jun 13, 2024 - 3 days
Bollinger Sell Nov 30, -1 - N/A days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Eupraxia Pharmaceuticals Inc.

Eupraxia Pharmaceuticals. Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis, as well as under development for treating canine and equine osteoarthritis. Its products in development al... EPRX.TO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT